Vasopressin Injection recall — Class II (D-0507-2024) · pharmaranks
Class IITerminated
Vasopressin Injection recall
FDA recall D-0507-2024 · initiated May 13, 2024
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Subpotent product in addition to having out-of-specification results for impurities.
Details
Product
Vasopressin Injection, USP, 200 Units per 10 mL (20 Units per mL), 10 mL Multiple-Dose Vial, Rx only, For Intravenous Infusion, American Regent, Inc., Shirley, NY 11967, NDC 0517-1030-01
Recalling company
American Regent, Inc.
Classification
Class II
Status
Terminated
Type
Voluntary: Firm initiated
Distribution
USA Nationwide
Initiated
May 13, 2024
FDA report date
May 29, 2024
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.